EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid

Aleksandra M Wojtas, Eric B Dammer, Qi Guo, Lingyan Ping, Ananth Shantaraman, Duc M Duong, Luming Yin, Edward J Fox, Fatemeh Seifar, Edward B Lee, Erik C B Johnson, James J Lah und 5 weitere

Alzheimer's & Dementia · 2024-06 · 20 (6) · 4043-4065

DOI: 10.1002/alz.13821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 07.05.2024. Verfasst von Aleksandra M Wojtas und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Biomarkers, Alzheimer Disease, Proteomics. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Cerebrovascular dysfunction is a pathological hallmark of Alzheimer's disease (AD). Nevertheless, detecting cerebrovascular changes within bulk tissues has limited our ability to characterize proteomic alterations from less abundant cell types. METHODS We conducted quantitative proteomics on bulk brain tissues and isolated cerebrovasculature from the same individuals, encompassing control ( N = 28), progressive supranuclear palsy (PSP) ( N = 18), and AD ( N = 21) cases. RESULTS Protein co‐expression network analysis identified unique cerebrovascular modules significantly correlated with amyloid plaques, cerebrovascular amyloid angiopathy (CAA), and/or tau pathology. The protein products within AD genetic risk loci were concentrated within cerebrovascular modules. The overlap between differentially abundant proteins in AD cerebrospinal fluid (CSF) and plasma with cerebrovascular network highlighted a significant increase of matrisome proteins, SMOC1 and SMOC2, in CSF, plasma, and brain. DISCUSSION These findings enhance our understanding of cerebrovascular deficits in AD, shedding light on potential biomarkers associated with CAA and vascular dysfunction in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAlzheimer DiseaseProteomicsHumansMaleAgedFemaleBrainTauopathiesSupranuclear Palsy, ProgressiveCerebral Amyloid AngiopathyMiddle AgedAged, 80 and overtau Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseamyloidbiomarkerscerebral amyloid angiopathycerebrovasculaturemass spectrometryprogressive supranuclear palsytandem mass tag labelingtau

Substanzen

Biomarkerstau Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Pennsylvania, USA.
  • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Alzheimer's Association
  • National Institutes of Health

Zitieren

APA

Wojtas, A. M., Dammer, E. B., Guo, Q., Ping, L., Shantaraman, A., Duong, D. M., Yin, L., Fox, E. J., Seifar, F., Lee, E. B., Johnson, E. C. B., Lah, J. J., Levey, A. I., Levites, Y., Rangaraju, S., Golde, T. E., & Seyfried, N. T. (2024). Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid. Alzheimer's & Dementia, 20(6), 4043-4065. https://doi.org/10.1002/alz.13821

Vancouver

Wojtas AM, Dammer EB, Guo Q, Ping L, Shantaraman A, Duong DM, et al. Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid. Alzheimer's & Dementia. 2024;20(6):4043-4065. doi:10.1002/alz.13821

BibTeX
@article{Wojtas2024,
  author = {Wojtas, Aleksandra M and Dammer, Eric B and Guo, Qi and Ping, Lingyan and Shantaraman, Ananth and Duong, Duc M and Yin, Luming and Fox, Edward J and Seifar, Fatemeh and Lee, Edward B and Johnson, Erik C B and Lah, James J and Levey, Allan I and Levites, Yona and Rangaraju, Srikant and Golde, Todd E and Seyfried, Nicholas T},
  title = {Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {6},
  pages = {4043--4065},
  doi = {10.1002/alz.13821}
}
Kostenlos starten →